Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04QUG
|
|||
| Former ID |
DIB003746
|
|||
| Drug Name |
A-101
|
|||
| Synonyms |
A-101; AC1L4MEL; AC1Q1Z6J; N-Phenylacetoaminomethylene-DL-p-nitrophenylalanine; 4-nitro-n-{[(phenylacetyl)amino]methyl}-l-phenylalanine; MALANEHOOMRDSZ-INIZCTEOSA-N; 70172-42-8; DL-Phenylalanine, 4-nitro-N-(((phenylacetyl)amino)methyl)-; (S)-alpha-[[[(Phenylacetyl)amino]methyl]amino]-p-nitrobenzenepropanoic acid; (2S)-3-(4-nitrophenyl)-2-[[(2-phenylacetyl)amino]methylamino]propanoic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cardiovascular disease [ICD-11: BA00-BE2Z; ICD-10: I00-I99] | Phase 2 | [1] | |
| Company |
Anthera Pharmaceuticals Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H19N3O5
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CC(=O)NCNC(CC2=CC=C(C=C2)[N+](=O)[O-])C(=O)O
|
|||
| InChI |
1S/C18H19N3O5/c22-17(11-13-4-2-1-3-5-13)20-12-19-16(18(23)24)10-14-6-8-15(9-7-14)21(25)26/h1-9,16,19H,10-12H2,(H,20,22)(H,23,24)/t16-/m0/s1
|
|||
| InChIKey |
MALANEHOOMRDSZ-INIZCTEOSA-N
|
|||
| CAS Number |
CAS 70172-42-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02160626) Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.